These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 23468064)

  • 21. Double-negative feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis.
    Zhang J; Yang Y; Yang T; Yuan S; Wang R; Pan Z; Yang Y; Huang G; Gu F; Jiang B; Lin C; Zhou W
    Hepatology; 2015 Feb; 61(2):561-73. PubMed ID: 25251503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E; Vogt A; Sauerbruch T; Schmitz V
    J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y; Xue JL; Shen Q; Chen J; Tian L
    Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.
    Cheng J; Chen Y; Zhao P; Liu X; Dong J; Li J; Huang C; Wu R; Lv Y
    Oncotarget; 2016 May; 7(21):30702-11. PubMed ID: 27120793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.
    Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM
    Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21.
    Shih YT; Wang MC; Zhou J; Peng HH; Lee DY; Chiu JJ
    Gut; 2015 Jul; 64(7):1132-47. PubMed ID: 24939570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
    Zhang JF; He ML; Fu WM; Wang H; Chen LZ; Zhu X; Chen Y; Xie D; Lai P; Chen G; Lu G; Lin MC; Kung HF
    Hepatology; 2011 Dec; 54(6):2137-48. PubMed ID: 21809363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
    Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
    Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycomb chromobox 4 enhances migration and pulmonary metastasis of hepatocellular carcinoma cell line MHCC97L.
    Mei Z; Jiao H; Wang W; Li J; Chen G; Xu Y
    Sci China Life Sci; 2014 Jun; 57(6):610-7. PubMed ID: 24838576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
    Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH
    Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
    Korhan P; Erdal E; Atabey N
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
    Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
    Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.